Other explanations for the difference between our findings and previous studies may be that it was caused by differences in the BMI, the more intensive treatment of diabetes mellitus, a higher number of individuals being treated with somatotropin, or differences in healthcare systems. Here, GH1 is linked to diabetes mellitus.